Skip to main contentSkip to main content
Updating results

Food And Drug Administration

  • Updated

FRIDAY, Nov. 18, 2022 (HealthDay News) -- The U.S. Food and Drug Administration on Thursday approved the first drug that could delay the development of stage 3 type 1 diabetes in adults and children 8 years and older who currently have stage 2 type 1 diabetes.

  • Updated

FRIDAY, Nov. 18, 2022 (HealthDay News) -- The U.S. Food and Drug Administration is warning consumers to be careful when buying prescription medication online. While some pharmacy websites operate legally and can offer convenience, privacy, and lower costs, others may be selling unapproved, counterfeit, and unsafe medications.

  • Updated

TUESDAY, Nov. 15, 2022 (HealthDay News) -- The U.S. Food and Drug Administration approved the combination of tremelimumab (Imjudo) plus durvalumab (Imfinzi) and platinum-based chemotherapy for adult patients with metastatic non-small cell lung cancer with no sensitizing epidermal growth factor receptor mutation or anaplastic lymphoma kinase genomic tumor aberrations.

  • Updated

THURSDAY, Nov. 10, 2022 (HealthDay News) -- About 11.3 percent of all middle and high school students reported currently using any tobacco product in 2022, with electronic cigarettes the most commonly used product, according to research published in the Nov. 11 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

  • Updated

WEDNESDAY, Nov. 9, 2022 (HealthDay News) -- The U.S. Food and Drug Administration on Tuesday warned health care workers to look out for patients who may have been exposed to a potentially deadly animal sedative, possibly through illicit drug use. The veterinary medication xylazine is sometimes added to fentanyl, heroin, or other drugs after either being diverted from the legal animal supply or illicitly produced, the FDA said.

Get up-to-the-minute news sent straight to your device.

Topics

Breaking News

News Alert